World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
47090
World Ranking
4225
National Ranking
126

Overview

Piero Picci is affiliated with the University of Bologna in Italy and has a primary focus in the field of medicine, with a significant contribution to pulmonary and respiratory medicine, rheumatology, neurology, oncology, and pathology and forensic medicine. Their research spans a range of clinical and pathological subjects, emphasizing tumor diagnosis and treatment.

The scientist's work frequently addresses topics related to:

  • Sarcoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Vascular Tumors and Angiosarcomas
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Neurofibromatosis and Schwannoma Cases
  • Cardiac tumors and thrombi

Piero Picci has contributed to multiple papers including:

  • Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups, 2020, Journal of Clinical Oncology
  • Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma, 2020, JAMA Oncology
  • Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial, 2021, Cancer
  • The sacral chordoma margin, 2020, European Journal of Surgical Oncology
  • Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab, 2021, BMC Cancer

The scientist's work has been published extensively in various venues, with highest frequency in:

  • Journal of Clinical Oncology
  • Cancers
  • Cancer
  • European Journal of Surgical Oncology
  • BMC Cancer

Frequent coauthors collaborating with Piero Picci include:

  • Emanuela Palmerini
  • Giovanni Grignani
  • Davide María Donati
  • Marco Gambarotti
  • Alessandra Longhi

The body of work reflects research concentrated on the challenges of diagnosis and treatment of soft tissue sarcomas and bone tumors, as well as addressing genetic susceptibilities in oncology patients. The collaboration network and publication history indicate active engagement with clinical trials and multidisciplinary research in tumor pathology and therapy.

Best Publications

  • Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

    Sergio Frustaci;Franco Gherlinzoni;Antonino De Paoli;Marco Bonetti

  • Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.

    Gaetano Bacci;Alessandra Longhi;Michela Versari;Mario Mercuri

  • Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P.G. Casali;N. Abecassis;S. Bauer;R. Biagini

  • Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Nathalie Gaspar;Douglas S. Hawkins;Uta Dirksen;Ian J. Lewis

  • Osteosarcoma (Osteogenic sarcoma)

    Piero Picci

  • Unicameral and aneurysmal bone cysts.

    Mario Campanacci;Rodolfo Capanna;Piero Picci

  • Platelet-derived growth factors enhance proliferation of human stromal stem cells.

    Enrico Lucarelli;Amira Beccheroni;Davide Donati;Luca Sangiorgi

  • Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

    Stefano Ferrari;Sigbjorn Smeland;Mario Mercuri;Franco Bertoni

  • Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Paolo G. Casali;Jean-Yves Blay;Alexia Bertuzzi;Stefan Bielack

  • Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report

    Gaetano Bacci;Stefano Ferrari;Franco Bertoni;Pietro Ruggieri

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • Chordoma of the mobile spine: fifty years of experience.

    Stefano Boriani;Stefano Bandiera;Roberto Biagini;Patrizia Bacchini

  • Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome

    Nicola Baldini;Katia Scotlandi;Giovanni Barbanti-Bròdano;Maria Cristina Manara

  • The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation

    Andrew S. Brohl;David A. Solomon;Wendy Chang;Jianjun Wang

  • Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

    Gaetano Bacci;Piero Picci;Stefano Ferrari;Pietro Ruggieri M.D.

  • Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.

    P Picci;L Sangiorgi;B T Rougraff;J R Neff

  • A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

    G Grignani;Emanuela Palmerini;P. Dileo;S. D. Asaftei

  • Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival

    Stefano Ferrari;Antonio Briccoli;Mario Mercuri;Franco Bertoni

  • Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution

    Emanuela Palmerini;Eric L. Staals;Marco Alberghini;Licciana Zanella

Frequent Co-Authors

Katia Scotlandi
Katia Scotlandi Wayne State University
Mario Mercuri
Mario Mercuri University of Bologna
Franco Bertoni
Franco Bertoni Ospedale San Donato
Paolo G. Casali
Paolo G. Casali University of Milan
Angelo Paolo Dei Tos
Angelo Paolo Dei Tos University of Padua
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Alessandro Gronchi
Alessandro Gronchi University of Milan
Nicola Baldini
Nicola Baldini University of Bologna
Sakari Knuutila
Sakari Knuutila University of Helsinki
David W. P. Thomas
David W. P. Thomas University of Nottingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean attending medical school. There are several affordable online programs that offer alternative pathways into the healthcare field. For those drawn to health data, an online MHI (Master’s in Health Information) provides advanced skills in managing and analyzing medical information.

Medical billing and coding is a critical part of healthcare administration. If you’re curious about costs, find out how much is medical billing and coding school and explore affordable options that can help you start your career in this growing field.

Nurses looking to advance their practice can consider the cheapest FNP programs (Family Nurse Practitioner) or pursue an MSN. There are opportunities for aspiring nurses to find the cheapest online MSN programs and earn advanced credentials without the burden of high tuition.

These online options offer flexibility and accessibility, opening doors to various healthcare careers beyond the traditional path of becoming a physician.

Best Scientists Citing Piero Picci

Trending Scientists